MAGNITUDE AND TIMING OF CHANGE IN MONITORING PARAMETERS FOR TRANSTHYRETIN AMYLOIDOSIS CARDIOMYOPATHY PATIENTS TREATED AND UNTREATED WITH TAFAMIDIS | Publicación